ing here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hard to trust someone when they lie to you
We need news and not the fluff news
News on otc also
We never used it we thought if we did they wouldn't put it on the billboard. Tonight FreeBeer.
Maybe, somebody just tookout the 8's
2 stocks he was at the last 2 days are green today
We always joked about that band name when I used to play bars/clubs.
That is the name of the band.
Consolidation?
Thats nice
Attorney letter out
Yep thats what i was thinking also. A pr comes out people buy in but it goes nowhere. Its seems it is being dumped on. Now no one buys and its slowly going to the bottom. I just started trackng to see how often and how much the os and unrestricted goes up.
For a couple bucks?
Who is dumping down here? Company?
LOS ANGELES, March 16, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce that the company has recently submitted their application for their planned minoxidil hair regrowth product for FDA registration status approval. The FDA registration process should be relatively quick, and we expect this process to be completed within a few weeks.
The company has chosen Nupelo as the brand name for its new hair regrowth product. Nupelo will incorporate ViaDerrma’s proprietary, patent-pending dual carrier transdermal delivery technology and use Minoxidil (topical route) in their new hair regrowth product.
ViaDerma plans to make Nupelo available for purchase via several online platforms including their newly acquired domain, nupelo.com. The product is expected to be ready to go to market and available to purchase online by the end of Q2 2023.
"Everything has really come together very quickly and smoothly. Due to the extreme effectiveness of our proprietary transdermal delivery system, we are able to develop new products like Nupelo in a very short period of time. Many other hair products only work to reduce hair loss, but are ineffective at actually regrowing hair. Nupelo works to solve both," said ViaDerma’s President & CEO, Dr. Chris Otiko.
About ViaDerma, Inc.
ViaDerma, Inc. (OTC: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. For more information, visit: https://viaderma.com
Any forecast of future performance is a "forward looking statement" under securities laws. Such statements are included to allow potential investors the opportunity to understand management’s beliefs and opinions with respect to the future so that they may use such beliefs and opinions as one factor among many in evaluating an investment.
Contact information:
Investor Relations
Email: ir@viaderma.com
Phone: 310-734-6111
Follow ViaDerma on Twitter: https://twitter.com/viaderma
Follow ViaDerma on Facebook: https://www.facebook.com/ViaDermaLicensing/
News out.
Plus all other bids
Skipped right over the 9mil at .0103
Saw that. What do you think
why not wait 2 days and put out the news and finances
Attorney letter out
Went pink today
half dozen of my otc stocks are actively trading on tda. the other 30 or so are not
6 out of 25 on my watch list show trading activity on tda.
same here some of mine trading some not. seems just the otc.
Classical gas
XCPCNL Business Services Announces Launch of Customer Service Experience Predictor developed from Centiment Capital IP
Press Release | 12/05/2022
Charlotte, North Carolina, Dec. 05, 2022 (GLOBE NEWSWIRE) -- XCPCNL Business Services Corporation (OTC Pink: XCPL), a venture development business that leverages knowledge, skill, and experience in the consumer products industry, is excited to announce that the company has successfully developed a Centiment Capital IP that has been commercialized into a B2C product called CSEP(Customer Service Experience Predictor).
CSEP is a system that anticipates customer sentiment for inbound customer service call centers. The objective for clients will be the following:
Building Effective Engagement and Brand Value
Improving Customer Satisfaction
Driving Effective Engagement, Market Share and ROI
Currently, we are in a beta test with a Fortune 100 client in the banking Industry, collecting and synthesizing their caller data from social media using known attributes. We then analyze the data using the Centiment.io AI IP to develop a sentiment rating for those callers. Once the beta test is completed, we will license the software to this client for them to sell to their clients, generating a new revenue stream for XCPCNL.
“This is a significant step for us, as we have stated our goal was to commercialize Centiment Capital IP’s to develop B2B and B2C products. Though we have not completed the merger in totality, we are creating revenue driving products to ensure XCPCNL’s long term growth and continue to build Shareholder value. This is the benefit of raising capital to cover development costs and IP development” said CEO Tim Matthews.
XCPCNL Business Services Corporation (OTC Pink: XCPL) encourages shareholders to visit their corporate Twitter account at https://twitter.com/RealXCPCNL.
Forward-Looking Statements Disclaimer:
This press release may include, and oral statements made from time to time by representatives of the Company may have, "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof and related matters, as well as all other statements other than statements of historical fact included in this press release, are forward-looking statements. When used in this press release, words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions, as they relate to our management team or us, identify forward-looking statements. Such forward-looking statements are based on management's beliefs, as well as assumptions made by, and information currently available to, the Company's management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company's filing with the Over-the-Counter Market ("OTC"). All subsequent written or forward-looking oral statements attributable to persons or us acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
About XCPCNL
Charlotte, NC-based XCPCNL Business Services is a venture development business that leverages its knowledge, skills, and experience in the consumer products industry. Our primary mission is to provide marketing, technology, and other business services to fast-growing consumer product companies and big-box retailers. XCPCNL is a minority-owned and controlled firm. To learn more about our businesses, services, and opportunities, please contact: info@xcpcnl.com.
To learn more about XPCNL, visit www.xcpcnl.com.
For Inquiries:
Email: ir@xcpcnl.com
Attachment
XCPCNL Business Services Announces Launch of Customer Service Experience Predictor developed from Centiment Capital IP
Primary Logows out
No i don't
What happened to the chart on the main page?
It is back to pink
Update out
paul drop to .0075
When are filings expected?
Quarterly out
Filings out
6s dissapeared just like the 5s yesterday
When does the d come off?
Its on otc financial reports
Just posting a fact from what I can see.
Agreed. I have no idea where the shares are coming from.